A carregar...
Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin
Periprosthetic osteolysis belongs to osteolytic diseases, which often occur due to an imbalance between osteoclast and osteoblast number or activity. Fraxetin, a natural plant extract, inhibits osteoblast apoptosis and has therapeutic potential for treating osteolytic diseases. However, data pertain...
Na minha lista:
| Publicado no: | Int J Mol Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089765/ https://ncbi.nlm.nih.gov/pubmed/29786751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3698 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|